Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|January 17, 2023
Structural and Biochemical Features of OXA-517: a Carbapenem and Expanded-Spectrum Cephalosporin Hydrolyzing OXA-48 VariantLaura Dabos, Joanna E Raczynska, Pierre Bogaerts, et al.
Plos One|March 29, 2019
Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015Katrien Latour, Te-Din Huang, Béatrice Jans, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 30, 2022
Characterization of hypervirulent Klebsiella pneumoniae isolates in BelgiumAhalieyah Anantharajah, Matthieu Deltombe, Marie de Barsy, et al.
Antimicrobial Resistance and Infection Control|September 25, 2019
A recurrent and transesophageal echocardiography-associated outbreak of extended-spectrum β-lactamase-producing <i>Enterobacter cloacae</i> complex in cardiac surgery patientsTom Van Maerken, Els De Brabandere, Audrey Noël, et al.
Antimicrobial Agents and Chemotherapy|March 9, 2023
Development of Nanobodies as Theranostic Agents against CMY-2-Like Class C β-LactamasesFrédéric Cawez, Paola Sandra Mercuri, Francisco Javier Morales-Yãnez, et al.
Journal of Global Antimicrobial Resistance|January 13, 2022
Multicentre interlaboratory analysis of routine susceptibility testing with a challenge panel of resistant strainsCorentin Deckers, Reza Soleimani, Olivier Denis, et al.
Methods and Protocols|August 23, 2020
SARS-CoV-2 Detection for Diagnosis Purposes in the Setting of a Molecular Biology Research LabDamien Coupeau, Nicolas Burton, Noémie Lejeune, et al.
Antimicrobial Agents and Chemotherapy|May 29, 2026
Genetic and biochemical characterization of OXA-1054, a carbapenem-hydrolyzing class D β-lactamase conferring broad-spectrum β-lactam resistance in <i>Pseudomonas aeruginosa</i>Lucía González-Pinto, Laura Monge-Olivares, Gloria Pérez-Rodríguez, et al.
Pageof 9